tamoxifen
CONCLUSIONS: According       to the data of the recent EBCTG overview, an additional 20,000 lives could be       saved worldwide each year if tamoxifen were given to all early breast cancer       patients with hormone-sensitive disease, irrespective of age and disease stage,       and for a minimum of five years.
CONCLUSIONS: According       to the data of the recent EBCTG overview, an additional 20,000 lives could be       saved worldwide each year if  @SUBJECT$  were  @PREDICAT$  to all early breast cancer        @OBJECT$  with hormone-sensitive disease, irrespective of age and disease stage,       and for a minimum of five years.